IMNM earnings date and last-quarter result: last quarter miss, P/E -9.57. Updated 2026-07-23.
Immunome (IMNM) Research Hub
Immunome (IMNM) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 17.89 USD (-0.56%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -9.57, market cap 2.16B. This hub links to the full technical, earnings and options research available for IMNM.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 17.89 USD (-0.56%) |
| 52-week range | 16.42 USD – 30.06 USD |
| Trend regime | Range |
| 14-day RSI | 38.7 (Bearish) |
| Trailing P/E | -9.57 |
| Market cap | 2.16B |
| Dividend yield | 0.00% |
Available research for IMNM
Covered Call on IMNM: how it works, illustrative setup around the real 17.89 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on IMNM: how it works, illustrative setup around the real 17.89 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on IMNM: how it works, illustrative setup around the real 17.89 USD price, max profit/loss, breakeven and when to use it. Educational.
IMNM technical analysis: range, last 17.89 USD, RSI 38.7, 52w range 16.42 USD–30.06 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is IMNM in?
Immunome (IMNM) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is IMNM in an uptrend or downtrend?
As of 2026-10-26, IMNM is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is IMNM's trailing P/E ratio?
IMNM's trailing P/E is -9.57, with a market cap of 2.16B. See the earnings research page for full valuation detail.